Triclosan: The Antibacterial That Didn't Work Better Than Soap

In 2016, the FDAFood and Drug Administration pulled triclosan from consumer hand soaps — not primarily over health concerns, but because manufacturers couldn't demonstrate it worked any better than washing with plain soap and water. Forty years on the market. No proof it did what the label implied.

Triclosan is part of the broader story of chemicals that interact with your body in ways nobody tested for. The FDA ban removed it from one product category. The evidence on thyroid disruption, antibiotic resistance, and environmental persistence kept building — and the chemical is still in the waterways.

Triclosan (C₁₂H₇Cl₃O₂, CASChemical Abstracts Service 3380-34-5) is a synthetic chlorinated aromatic compound that kills bacteria by blocking an enzyme called enoyl-ACP reductaseAlso called FabI — a key enzyme in bacterial fatty acid synthesis. Triclosan binds to it and stops bacteria from building the cell membranes they need to survive.. First registered as a pesticide in 1969, it entered consumer personal care products in the 1970s and spent the next four decades in virtually everything marketed as antibacterial Weatherly and Gosse 2017. By 2001, a US market survey of 23 stores across 10 states found 76% of liquid antibacterial soaps contained triclosan or triclocarban (Perencevich 2001) of liquid antibacterial soaps in the sample contained triclosan or triclocarban as the active antimicrobial Perencevich et al. 2001.

Here's what makes that mechanism significant. FabI is also the target of isoniazid, a frontline antibiotic for tuberculosis. When a chemical that hits the same molecular target as a clinical antibiotic gets added to hand soap used by millions of people daily, it creates selective pressure for resistance — not in a controlled hospital setting, but in every kitchen drain and wastewater system in the country. That concern turned out not to be theoretical.

At concentrations ranging from 0.1% to 1%, triclosan was added to consumer products across virtually every room in the house. The regulatory landscape has shifted since 2016, but the product history explains how the chemical reached three out of four Americans.

The most visible triclosan product was Colgate Total, which contained 0.3% triclosan as its active antibacterial ingredient for over two decades — one of several chemicals worth knowing about in your oral care products. Colgate reformulated the line in January 2019, replacing triclosan with stannous fluorideA fluoride compound with mild antibacterial properties — the active ingredient in most current 'Total'-branded toothpastes.. No major US, UK, or EU toothpaste brand currently uses triclosan. The market moved faster than the regulations required it to.

What's worth understanding is why Colgate Total survived the 2016 wash ban in the first place. The 2016 rule (81 FR 61106) finalised FDA's tentative final monograph for over-the-counter consumer antiseptic washes — a regulatory pathway covering hand and body soaps sold without a prescription. Colgate Total was never on that pathway. It had been approved as a drug under New Drug Application 020231 on 1997 — specifically July 11 — on the basis of clinical trial data showing plaque and gingivitis reductions when triclosan was paired with a polymer that helped it stick to the gum line. A 2013 Cochrane review of 30 trials with 14,835 participants graded that evidence as moderate-quality for plaque and gingivitis, and high-quality for a roughly 5% reduction in coronal caries Riley and Lamont 2013. Total had its own clinical file; the 2016 rule covered a different category of product.

The carve-out was structural, not scientific. The FDA didn't reaffirm triclosan's safety in toothpaste — it simply hadn't ruled on toothpaste. The agency's 1994 reproposal of the antiseptic monograph never reached the oral-care category, and Colgate's NDA had its own evidence base outside the soap rulemaking entirely. Banned from the soap dispenser. Permitted in the toothpaste tube. Same drain. By the time Colgate reformulated voluntarily in 2019 — citing evolving consumer preferences, not safety — competitors had already moved on and the product had outlived its category.

What didn't disappear is the environmental load. The US Geological Survey sampled 139 streams across thirty states between 1999 and 2000 and found triclosan among the seven most frequently detected organic wastewater contaminants out of 95 compounds tested Kolpin et al. 2002. It survives conventional wastewater treatment. In a 2005 sampling off the Charleston coast, Fair and colleagues drew plasma from 13 wild Atlantic bottlenose dolphins and found triclosan in 31% of them — concentrations from 0.12 to 0.27 ng/g of plasma, mean 0.18 ng/g Fair et al. 2009. A second cohort off the Indian River Lagoon in Florida carried lower but still detectable concentrations. From the bathroom sink to dolphin blood. The product is gone. The chemical isn't.

The clinical question was settled in 2007. Aiello, Larson, and Levy reviewed every controlled trial that had compared triclosan-containing consumer soaps against plain soap — studies where people washed their hands normally and researchers tracked illness rates and bacterial counts afterward. Across consumer concentrations of 0.1-0.45%, triclosan soap performed identically to plain soap at reducing illness and hand bacteria Aiello et al. 2007. Not marginally worse. Not slightly better. The same. The FDA cited this as the foundation for the 2016 ban.

The health concerns are separate from the efficacy failure. Paul and colleagues gave triclosan to young Long-Evans rats — weanlings, chosen because developing thyroid systems are more sensitive to disruption — at escalating doses over four days. They measured circulating thyroxineT4 — the primary hormone produced by the thyroid gland. Regulates metabolism, heart rate, body temperature, and brain development. and the liver enzymes responsible for clearing it. At the highest dose, total T4 dropped to 43% of control levels at 1000 mg/kg/day — less than half the normal circulating thyroxine of normal levels. The mechanism was clear: triclosan ramped up the liver's T4 clearance machinery, with PRODpentoxyresorufin-O-dealkylase — a liver enzyme that metabolizes and clears thyroid hormones from the body activity reaching nine times baseline — the liver clearing thyroid hormone faster than the gland could replace it Paul et al. 2010. Crofton's group had documented the same dose-dependent T4 decline in a shorter study two years earlier, with a benchmark dose of 69.7 mg/kg/day Crofton et al. 2007. The pattern is consistent: triclosan accelerates thyroid hormone clearance through the liver.

Whether that mechanism translates to humans was the question Wang and colleagues set out to answer in a Shanghai birth cohort enrolled between 2012 and 2013. They recruited 398 mother-infant pairs, collected a single spot urine sample from each woman near the end of pregnancy — 38.8 weeks on average — measured triclosan in the urine, and matched it to thyroid hormone panels drawn from maternal blood and from cord blood at delivery. Every tenfold increase in maternal urinary triclosan was associated with a 1.98% drop in maternal free thyroxineFT4 — the unbound, biologically active fraction of thyroxine in the bloodstream, and infants in the medium and high triclosan tertiles had cord blood free triiodothyronineFT3 — the more metabolically active thyroid hormone, converted from FT4 levels 0.11 pmol/L lower than infants in the low-exposure group Wang et al. 2017. The associations held after adjustment for maternal age, education, BMI, parity, and gestational age, though not for iodine status — a methodological caveat the authors acknowledged.

The human signal is mixed. A 2020 meta-analysis pooled seven studies covering 4,136 participants and found no overall association between prenatal triclosan and maternal FT4 or TSH — the effect across cohorts averaged out to roughly zero Chen et al. 2020. What's consistent across rodent and human work is the mechanism, not the magnitude. The animal data show how triclosan accelerates hepatic thyroxine clearance; the human cohorts vary depending on iodine status, sampling design, and how triclosan was measured. The Wang cohort sampled urine once at the end of pregnancy — a snapshot of an exposure that varies daily. That's a real limitation, and it's part of why the meta-analytic effect is null.

Here's the finding that reframes the entire story. Lu and colleagues at the University of Queensland took wild-type E. coliEscherichia coli — a common gut bacterium. 'Wild-type' means the normal, non-resistant strain — the baseline that antibiotics should easily kill. — ordinary, non-resistant bacteria — and exposed them to triclosan at 0.2 mg/L — roughly one drop of liquid in a full bathtub — a concentration plausible for environmental exposure. They waited thirty days. The bacteria mutated. Genes governing efflux pumpsMolecular machinery in bacterial cell walls that actively pumps antibiotics out of the cell before they can work — one of the main mechanisms of antibiotic resistance. and beta-lactamasesEnzymes that break down beta-lactam antibiotics like penicillin and ampicillin — the most commonly prescribed class of antibiotics worldwide. switched on — five genes in total: fabI, frdD, marR, acrR, and soxR. The E. coli could now survive multiple antibiotic classes that had killed the parent strain Lu et al. 2018.

A chemical marketed as killing bacteria, breeding bacteria that antibiotics can't kill. The irony is structural: triclosan targets the same enzyme family as certain clinical antibiotics, so environmental exposure pre-selects for the same resistance mutations that make infections harder to treat.

In mouse models, triclosan also accelerated liver tumor development. Yueh and colleagues used a two-stage cancer protocol — DENdiethylnitrosamine — a chemical used to initiate liver cancer in laboratory models to initiate tumors, then triclosan to promote them — and found it substantially drove hepatocellular carcinomaThe most common type of primary liver cancer. progression through the CARconstitutive androstane receptor — a nuclear receptor in the liver that regulates drug metabolism and cell proliferation pathway, with the authors specifically excluding PPARαperoxisome proliferator-activated receptor alpha — a different nuclear receptor often invoked for liver pathology as the mechanism Yueh et al. 2014. This is tumor promotion, not initiation — triclosan didn't cause cancer on its own, but accelerated growth in already-initiated cells. IARCInternational Agency for Research on Cancer has not classified triclosan.

Triclosan's thyroid effects get the attention because the mechanism is clean and the doses are bracketed in animal work. Less discussed is that the chemical also touches the estrogen and androgen pathways — both at receptors and in functional reproductive endpoints. Stoker and colleagues ran a pair of standard regulatory assays in female Wistar rats at the EPA's Endocrine Disruptor Screening Program. Triclosan alone advanced vaginal opening and increased uterine weight at oral doses of 150 mg/kg, and at much lower co-doses — 4.69 mg/kg and above — it potentiated the estrogenic response to ethinyl estradiol. The same animals showed thyroxine suppression, consistent with Paul and Crofton Stoker et al. 2010.

The dose levels matter for honesty. Stoker's group explicitly noted that the lowest effective rodent doses were roughly ten times higher than the highest triclosan concentrations measured in human plasma for the estrogenic effect, and forty times higher for the thyroid effect. This isn't a paper saying triclosan does to people what it did to those rats. It's a paper saying the receptor activity is real — and the gap between exposure and effect is the kind of safety margin regulators often defend, but rarely enlarge once a chemical is on the market.

Receptor-binding work tells a more complicated story. Gee and colleagues, working in human breast cancer cells (MCF7) and rat tissue, found that triclosan displaces both [3H]oestradiol from estrogen receptors and [3H]testosterone from the androgen receptor — and the functional consequences depend entirely on dose. At 1 µM in MCF7 cells, triclosan increased estrogen-driven growth (weakly estrogenic). At 10 µM, it completely inhibited the same response (anti-estrogenic at high doses). In androgen reporter assays, triclosan was anti-androgenic at sub-micromolar concentrations Gee et al. 2008. Estrogenic at one dose, anti-estrogenic at another, anti-androgenic at a third. Triclosan isn't a simple endocrine disruptor — it's a promiscuous one. That makes risk assessment harder, not easier.

Triclosan is the rare consumer chemical where regulation has actually moved. The FDA banned it from consumer hand soaps in 2016, the EU tightened restrictions in 2024, and Colgate voluntarily pulled it from its flagship toothpaste in 2019. The action was partial, staggered, and a generation behind the evidence — but it happened.

The pace of that regulation is its own story. The FDA's tentative final monograph for OTC topical antimicrobials was reproposed in June 1994 — the agency had been collecting data on triclosan and triclocarban for decades by that point. Twenty-two years later, the wash rule was finalised. The catalyst wasn't new evidence; it was a 2010 lawsuit from the Natural Resources Defense Council that produced a 2013 consent decree obligating the FDA to publish a final rule by a specific deadline. Court order, then rulemaking. The 2016 rule wasn't the regulatory system catching up — it was the regulatory system being made to catch up.

The FDA's rule banned 19 antimicrobial active ingredients — including triclosan and triclocarbanA related antimicrobial chemical used in bar soaps. Also banned by the FDA's 2016 rule for the same lack of efficacy evidence. — from consumer antiseptic wash products only. Hand sanitizers, healthcare antiseptics, first-aid products, and toothpaste remain outside its scope. The EU went further with Commission Regulation 2024/996: triclosan banned from mouthwash entirely, capped at 0.3% in the remaining permitted cosmetic categories, and required to carry a 'not for use in children under 3' label on the toothpaste it's still permitted in.

The 2016 rule didn't replace triclosan with safer alternatives — it deferred final rulemaking on three other antimicrobials that took its place: benzalkonium chloride, benzethonium chloride, and chloroxylenol. The FDA renewed those deferrals in 2017 and again in the healthcare antiseptics rule (82 FR 60474). None of the three has ever been formally adjudicated by the agency. The replacement chemicals on consumer soap shelves haven't been declared generally recognised as safe and effective. They've been left in regulatory limbo while the chemical they replaced got a final ruling — a quieter version of the regrettable-substitution pattern that runs through this library.

Triclosan has been removed from the product categories where exposure was highest — consumer hand and body soaps, the products people used daily at concentrations up to 0.45%. The practical picture is simpler than most chemicals in this library, and the eso-friendly alternative is one you already own: plain soap.

The honest assessment: if you're in the US, UK, or EU and buying mainstream personal care products, you're probably not encountering triclosan anymore. The shelves moved before most people noticed. The energy saved here is better directed at the chemicals that haven't been restricted — the phthalates hidden behind the word 'fragrance' and the forever chemicals still in non-stick coatings. Those don't have an FDA ban yet.

The soap in your office bathroom doesn't contain triclosan anymore. That's worth pausing on — for most chemicals in this library, you can't say the same thing. The regulatory system, for once, partially caught up. Twenty-two years after the FDA reproposed the monograph. Six years after a federal lawsuit forced the agency's hand. After the chemical had reached three out of four Americans' urine and the blood of dolphins off the Carolina coast.

The phthalates hiding behind the word 'fragrance' and the forever chemicals baked into non-stick surfaces — those chapters are still open. Triclosan at least got one. Most of the others are still waiting.